Atlas Trials

A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China

Clinical trial NCT03572231 · COMPLETED

Trial details

NCT number
NCT03572231
Sponsor
Astellas Pharma Singapore Pte. Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
Overactive Bladder (OAB)
Start date
2018-07-19
Primary completion
2020-03-30
Enrollment
805

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.